Companies / PFE vs MRK
PFE vs MRK: Pfizer and Merck
Pfizer (PFE) reported $62.6B in revenue against a 12.4% net margin, while Merck (MRK) reported $65.0B at a 28.1% net margin, most recently.
| Metric | PFE | MRK |
|---|---|---|
| Revenue | $62.6B | $65.0B |
| Net Income | $7.8B | $18.3B |
| Gross Margin | 74.3% | 74.8% |
| Operating Margin | — | — |
| EPS (Diluted) | $1.36 | $7.28 |
| Free Cash Flow | $9.1B | $12.4B |
| Total Debt | $64.8B | $49.3B |
| P/E Ratio | 18.3× | 14.5× |
| P/B Ratio | n/m | n/m |
| Stock Price | $29.90 | $147.90 |
Free: last 5 years
| Fiscal year | FY2007 🔒 | FY2008 🔒 | FY2009 🔒 | FY2010 🔒 | FY2011 🔒 | FY2012 🔒 | FY2013 🔒 | FY2014 🔒 | FY2015 🔒 | FY2016 🔒 | FY2017 🔒 | FY2018 🔒 | FY2019 🔒 | FY2020 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PFE Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $81.3B | $101.2B | $59.6B | $63.6B | $62.6B |
| MRK Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $48.7B | $59.3B | $60.1B | $64.2B | $65.0B |